Catabasis Pharmaceuticals to Report First Quarter 2018 Financial Results and Recent Corporate Developments on Thursday, May 10
May 03 2018 - 8:00AM
Business Wire
The Company Will Host a Conference Call at
8:30am ET
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage
biopharmaceutical company, will report first quarter 2018 financial
results before the NASDAQ Global Market open on Thursday, May 10,
2018. Jill C. Milne, Ph.D., Chief Executive Officer, will host a
conference call and webcast at 8:30am ET to provide an update on
corporate developments and to discuss first quarter financial
results.
Conference Call Dial-In
Information:
Participant Toll-Free Dial-In Number: (877) 388-2733 Participant
International Dial-In Number: (541) 797-2984 Pass Code: 2192025
Please specify to the operator that you would like to join the
“Catabasis First Quarter 2018 Results Call.”
Interested parties may access a live audio webcast of the
conference call via the investor section of the Catabasis website,
www.catabasis.com. Please connect to the Catabasis website several
minutes prior to the start of the broadcast to ensure adequate time
for any software download that may be necessary. The webcast will
be archived for 90 days.
About CatabasisAt Catabasis Pharmaceuticals, our mission
is to bring hope and life-changing therapies to patients and their
families. Our SMART (Safely Metabolized And Rationally Targeted)
Linker drug discovery platform enables us to engineer molecules
that simultaneously modulate multiple targets in a disease. Our
lead program in development is edasalonexent for the treatment of
Duchenne muscular dystrophy. For more information on edasalonexent
and our pipeline of drug candidates, please
visit www.catabasis.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180503005250/en/
Investor and Media ContactCatabasis
Pharmaceuticals, Inc.Andrea Matthews,
617-349-1971amatthews@catabasis.com
Catabasis Pharmaceuticals (NASDAQ:CATB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Catabasis Pharmaceuticals (NASDAQ:CATB)
Historical Stock Chart
From Apr 2023 to Apr 2024